CellTrans’ Donislecel: Insulin Independence Data May Offer Path To Market In Type 1 Diabetes

 
• By Sue Sutter
Pancreas secreting insulin
Restoration of insulin independence with pancreatic islet cell therapy would remove the risk of hypoglycemia from exogenous insulin. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers